DIP
EDIT icon

DT Investment Partners’s Editas Medicine EDIT Stock Holding History

DT Investment Partners’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$175 Hold
54
– – ﹤0.01% 507
2026
Q1 		$134 Hold
54
– – ﹤0.01% 513
2025
Q4 		$111 Hold
54
– – ﹤0.01% 538
2025
Q3 		$188 Hold
54
– – ﹤0.01% 528
2025
Q2 		$119 Hold
54
– – ﹤0.01% 526
2025
Q1 		$63 Hold
54
– – ﹤0.01% 548
2024
Q4 		$69 Hold
54
– – ﹤0.01% 552
2024
Q3 		$185 Buy
+54
New +$235 ﹤0.01% 623

Other funds holding EDIT

TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

DT Investment Partners's EDIT Position: Q2 2026 in Review

DT Investment Partners held its Editas Medicine (EDIT) position steady in Q2 2026 at 54 shares worth $175. The position accounts for ﹤0.01% of the portfolio, ranked #507.

DT Investment Partners first reported a position in EDIT in Q3 2024 and has held it in 8 quarters since. The position peaked at $188 in Q3 2025. 215 funds tracked by Wall St. Rank hold EDIT as of Q2 2026.

  • DT Investment Partners held 54 shares of Editas Medicine worth $175 as of Q2 2026.
  • DT Investment Partners left its Editas Medicine share count unchanged in Q2 2026.
  • Editas Medicine made up ﹤0.01% of DT Investment Partners's portfolio in Q2 2026, its #507 holding.
  • DT Investment Partners first reported a position in Editas Medicine in Q3 2024 and has held it in 8 quarters since.
  • DT Investment Partners's Editas Medicine position peaked at $188 in Q3 2025.
  • 215 funds tracked by Wall St. Rank held Editas Medicine as of Q2 2026.

Based on DT Investment Partners's 13F filing for Q2 2026, filed 27 Jul 2026.